Cetera Investment Advisers’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.01M Sell
15,436
-248
-2% -$51.4K ﹤0.01% 2040
2026
Q1
$3.52M Sell
15,684
-2
-0% -$498 ﹤0.01% 1768
2025
Q4
$3.78M Buy
15,686
+159
+1% +$40.7K ﹤0.01% 1667
2025
Q3
$4.25M Buy
15,527
+4,080
+36% +$1.11M ﹤0.01% 1536
2025
Q2
$2.95M Sell
11,447
-556
-5% -$133K 0.01% 1557
2025
Q1
$2.69M Sell
12,003
-602
-5% -$141K 0.01% 1541
2024
Q4
$2.88M Buy
12,605
+2,259
+22% +$544K 0.01% 1386
2024
Q3
$2.53M Buy
10,346
+625
+6% +$140K 0.01% 1449
2024
Q2
$1.86M Buy
9,721
+2,053
+27% +$417K ﹤0.01% 1626
2024
Q1
$1.52M Buy
7,668
+5,245
+216% +$961K ﹤0.01% 1758
2023
Q4
$417K Buy
+2,423
New +$372K ﹤0.01% 1588
2022
Q4
Sell
-1,641
Closed -$358K 2157
2022
Q3
$358K Sell
1,641
-344
-17% -$78.3K 0.01% 1168
2022
Q2
$416K Buy
1,985
+640
+48% +$136K 0.01% 1215
2022
Q1
$326K Buy
1,345
+347
+35% +$83.9K ﹤0.01% 1422
2021
Q4
$260K Sell
998
-1,241
-55% -$322K ﹤0.01% 1573
2021
Q3
$590K Sell
2,239
-443
-17% -$121K 0.01% 1042
2021
Q2
$661K Buy
2,682
+226
+9% +$47.5K 0.01% 965
2021
Q1
$477K Sell
2,456
-175
-7% -$35.1K 0.01% 1007
2020
Q4
$559K Buy
2,631
+667
+34% +$133K 0.01% 912
2020
Q3
$337K Buy
1,964
+407
+26% +$75.2K 0.03% 478
2020
Q2
$299K Buy
+1,557
New +$255K 0.03% 476

Other funds holding RMD

Cetera Investment Advisers's RMD Position: Q2 2026 in Review

Cetera Investment Advisers reduced its ResMed (RMD) stake by 1.6% in Q2 2026, selling an estimated $51.4K and leaving 15,436 shares worth $3.01M. The position accounts for ﹤0.01% of the portfolio, ranked #2040.

Cetera Investment Advisers first reported a position in RMD in Q2 2020 and has held it in 21 quarters since. The position peaked at $4.25M in Q3 2025. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Cetera Investment Advisers held 15,436 shares of ResMed worth $3.01M as of Q2 2026.
  • Cetera Investment Advisers sold 248 ResMed shares in Q2 2026, an estimated $51.4K.
  • ResMed made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #2040 holding.
  • Cetera Investment Advisers first reported a position in ResMed in Q2 2020 and has held it in 21 quarters since.
  • Cetera Investment Advisers's ResMed position peaked at $4.25M in Q3 2025.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.